BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29187174)

  • 41. Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1.
    Sveen A; Johannessen B; Tengs T; Danielsen SA; Eilertsen IA; Lind GE; Berg KCG; Leithe E; Meza-Zepeda LA; Domingo E; Myklebost O; Kerr D; Tomlinson I; Nesbakken A; Skotheim RI; Lothe RA
    Genome Med; 2017 May; 9(1):46. PubMed ID: 28539123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer.
    Eilertsen IA; Moosavi SH; Strømme JM; Nesbakken A; Johannessen B; Lothe RA; Sveen A
    Cancer Lett; 2020 Jan; 469():246-255. PubMed ID: 31678167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
    Casbas-Hernandez P; Sun X; Roman-Perez E; D'Arcy M; Sandhu R; Hishida A; McNaughton KK; Yang XR; Makowski L; Sherman ME; Figueroa JD; Troester MA
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):406-14. PubMed ID: 25465802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dissecting cancer heterogeneity based on dimension reduction of transcriptomic profiles using extreme learning machines.
    Wang K; Duan X; Gao F; Wang W; Liu L; Wang X
    PLoS One; 2018; 13(9):e0203824. PubMed ID: 30216380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females.
    García N; Salamanca F; Astudillo-de la Vega H; Curiel-Quesada E; Alvarado I; Peñaloza R; Arenas D
    BMC Cancer; 2005 Aug; 5():93. PubMed ID: 16060964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes.
    Li J; Ivansson E; Klevebring D; Tobin NP; Lindström LS; Holm J; Prochazka G; Cristando C; Palmgren J; Törnberg S; Humphreys K; Hartman J; Frisell J; Rantalainen M; Lindberg J; Hall P; Bergh J; Grönberg H; Czene K
    Clin Cancer Res; 2017 May; 23(10):2584-2592. PubMed ID: 27587435
    [No Abstract]   [Full Text] [Related]  

  • 47. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
    Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at
    Madsen MJ; Knight S; Sweeney C; Factor R; Salama M; Stijleman IJ; Rajamanickam V; Welm BE; Arunachalam S; Jones B; Rachamadugu R; Rowe K; Cessna MH; Thomas A; Kushi LH; Caan BJ; Bernard PS; Camp NJ
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):644-652. PubMed ID: 29650789
    [No Abstract]   [Full Text] [Related]  

  • 49. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.
    Yau C; Fedele V; Roydasgupta R; Fridlyand J; Hubbard A; Gray JW; Chew K; Dairkee SH; Moore DH; Schittulli F; Tommasi S; Paradiso A; Albertson DG; Benz CC
    Breast Cancer Res; 2007; 9(5):R59. PubMed ID: 17850661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcriptional regulation of normal human mammary cell heterogeneity and its perturbation in breast cancer.
    Pellacani D; Tan S; Lefort S; Eaves CJ
    EMBO J; 2019 Jul; 38(14):e100330. PubMed ID: 31304632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel RNA-Affinity Proteogenomics Dissects Tumor Heterogeneity for Revealing Personalized Markers in Precision Prognosis of Cancer.
    Wang L; Wrobel JA; Xie L; Li D; Zurlo G; Shen H; Yang P; Wang Z; Peng Y; Gunawardena HP; Zhang Q; Chen X
    Cell Chem Biol; 2018 May; 25(5):619-633.e5. PubMed ID: 29503206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ColoType: a forty gene signature for consensus molecular subtyping of colorectal cancer tumors using whole-genome assay or targeted RNA-sequencing.
    Buechler SA; Stephens MT; Hummon AB; Ludwig K; Cannon E; Carter TC; Resnick J; Gökmen-Polar Y; Badve SS
    Sci Rep; 2020 Jul; 10(1):12123. PubMed ID: 32694712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unraveling breast cancer heterogeneity through transcriptomic and epigenomic analysis.
    Orlando FA; Brown KD
    Ann Surg Oncol; 2009 Aug; 16(8):2270-9. PubMed ID: 19452229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiogenomic signatures reveal multiscale intratumour heterogeneity associated with biological functions and survival in breast cancer.
    Fan M; Xia P; Clarke R; Wang Y; Li L
    Nat Commun; 2020 Sep; 11(1):4861. PubMed ID: 32978398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new genome-driven integrated classification of breast cancer and its implications.
    Dawson SJ; Rueda OM; Aparicio S; Caldas C
    EMBO J; 2013 Mar; 32(5):617-28. PubMed ID: 23395906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adaptively capturing the heterogeneity of expression for cancer biomarker identification.
    Xie XP; Xie YF; Liu YT; Wang HQ
    BMC Bioinformatics; 2018 Nov; 19(1):401. PubMed ID: 30390627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine.
    Aleskandarany MA; Vandenberghe ME; Marchiò C; Ellis IO; Sapino A; Rakha EA
    Pathobiology; 2018; 85(1-2):23-34. PubMed ID: 29428954
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular subtyping of cancer: current status and moving toward clinical applications.
    Zhao L; Lee VHF; Ng MK; Yan H; Bijlsma MF
    Brief Bioinform; 2019 Mar; 20(2):572-584. PubMed ID: 29659698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers.
    Lau HSH; Tan VKM; Tan BKT; Sim Y; Quist J; Thike AA; Tan PH; Pervaiz S; Grigoriadis A; Sabapathy K
    NPJ Breast Cancer; 2023 Oct; 9(1):84. PubMed ID: 37863888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spatial Transcriptome-Wide Profiling of Small Cell Lung Cancer Reveals Intra-Tumoral Molecular and Subtype Heterogeneity.
    Zhang Z; Sun X; Liu Y; Zhang Y; Yang Z; Dong J; Wang N; Ying J; Zhou M; Yang L
    Adv Sci (Weinh); 2024 Jun; ():e2402716. PubMed ID: 38896789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.